More than a dental implant – brand matters

Independent landmark study shows significantly lower failure rate with Straumann dental implants.1

More than a dental implant – brand matters

Study design

Shor

t-ter

m

Early implant loss = If implant loss had occurred prior to connection of the supraconstruction

Study duration Patient number Implant number Investigated brands

2,765 11,311

Swedish Social Insurance Agency

Long

-term

Late implant loss = Evaluated 9 years after therapy

596 2,367

Nobel Biocare

StraumannOthers

Astra 30 %

41 %

19 %

10 %

StraumannOthers

Astra 32 %

40 %

19 %

9 %

Nobel Biocare

ResultsRisk of implant loss compared to Straumann dental implants,

expressed as “odds ratio” (OR)overall

154 implants lost (1.4 %);

121 patients affected (4.4 %).

StraumannNobel Biocare

⊗1.94statistically significant

Astra

⊗2.10statistically significant

Other Brands

⊗7.79statistically significant

Early

impl

ant l

oss

Late

impl

ant l

oss 46 implants

lost (2.0 %);

25 patients affected (4.2 %).

If implant loss had occurred prior to connection of the supraconstruction, it was scored as an early implant loss. If the loss had occurred afterward, it was considered a late implant loss.

ConclusionThese findings are extremely relevant for dentists and patients who want to choose an implant system on the basis of independent

published clinical evidence. They add to the unparalleled body of long-term clinical data supporting Straumann’s dental implant system. Impressive long-term outcomes have been reported with Straumann implants in other peer-reviewed publications,

including 10-year survival rates of 98.8% in more than 300 patients.2

Brand matters!Because one implant failure is one too much. So

urce

1 Der

ks J,

Håk

anss

on J,

Wen

nstr

öm JL

, Tom

asi C

, Lar

sson

M, B

ergl

undh

T. E

ffec

tive

ness

of I

mpl

ant T

hera

py A

naly

zed

in a

Sw

edis

h Po

pula

tion:

Ea

rly a

nd L

ate

Impl

ant L

oss.

J D

ent R

es. 2

014

Dec

11. [

Epub

ahe

ad o

f prin

t].

2 Bu

ser D

, Jan

ner S

F, W

ittn

eben

JG, B

rägg

er U

, Ram

seie

r CA

, Sal

vi G

E. 10

-yea

r sur

viva

l and

succ

ess r

ates

of 5

11 ti

tani

um im

plan

ts w

ith

a sa

ndbl

aste

d an

d ac

id-e

tche

d su

rfac

e: a

ret-

rosp

ecti

ve s

tudy

in 3

03 p

artia

lly e

dent

ulou

s pat

ient

s. C

lin Im

plan

t Den

t Rel

at R

es. 2

012

Dec

;14(6

):839

-51.

Straumann Nobel Biocare

⊗6.13not statistically

significant

Astra

⊗5.23not statistically

significant

Other Brands

⊗58.15statistically significant

International Headquarters Institut Straumann AG Peter Merian-Weg 12 CH-4002 Basel, Switzerland Phone +41 (0)61 965 11 11 Fax +41 (0)61 965 11 01

Straumann North American Headquarters Straumann USA, LLC 60 Minuteman Road Andover, MA 01810 Phone 800/448 8168 (US) 800/363 4024 (CA) Fax 978/747 2490 www.straumann.us www.straumann.ca

NAM

LIT

1097

1

1/15

© Straumann USA, LLC 2015. All rights reserved. Straumann® and/or other trademarks and logos from Straumann® that are mentioned herein are the trademarks or registered trademarks of Straumann Holding AG and/or its affiliates. All rights reserved.